100 Participants Needed

Surgical Approaches for Spondylolisthesis

AG
Overseen ByAndrew Glennie, MD
Age: Any Age
Sex: Any
Trial Phase: Academic
Sponsor: Nova Scotia Health Authority
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 2 JurisdictionsThis treatment is already approved in other countries

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment for spondylolisthesis?

Research shows that patients with degenerative spondylolisthesis who had decompression and fusion surgery had better outcomes than those with decompression alone. Additionally, a study on high-grade L5-S1 spondylolisthesis found positive results with reduction and fusion using a single posterior approach.12345

Is surgery for spondylolisthesis generally safe?

Surgical techniques like paraspinal muscle sparing and percutaneous screw fixation are considered safer than traditional methods, as they reduce muscle injury and complications. These minimally invasive approaches often lead to shorter hospital stays, quicker recovery, and less post-operative pain.678910

How does the surgical approach for spondylolisthesis differ from other treatments?

The surgical approach for spondylolisthesis, which includes spinal fusion and decompressive laminectomy, is unique because it combines techniques to relieve pressure on the spinal cord and stabilize the spine. This approach can be less invasive, reducing muscle trauma and recovery time compared to traditional methods, and may involve advanced techniques like 3D navigation to minimize radiation exposure.49101112

What is the purpose of this trial?

For the increasing numbers of patients undergoing fusion procedures for the degenerative lumbar spine, infection and re-operation can negatively impact outcomes. Numerous observational and retrospective reviews have shown advantages to para-median versus midline approaches; however, recent systematic reviews have shown a need for a well-powered, prospective randomized control trials comparing both exposures. As a step towards a long-term goal of an RCT to address this issue, the purpose of this pilot study is to gather initial data to examine whether operative approach impacts the short-term infection rate, re-operation rate, length of stay, and overall costs to the system. Patients deemed appropriate surgical candidates with single or two-level degenerative spondylolisthesis will be approached for participation, and randomized into either the midline or paramedian group. Initial follow-ups will be at 2 and 6 weeks, and 3 months. Infection rates, inpatient and outpatient adverse events, re-operation rates, radiation exposure and costs will be determined. Cost effectiveness analysis will be estimated comparing each procedure using a bottom-up estimation. Post-operative wound infection can have a significant effect on patient short and long term outcomes. If a significant difference in infection rate is demonstrated, as well as lower re-operation rates, shorter stays, and decreased overall costs, adoption of paramedian approaches to single or two-level fusions of the lumbar spine might be suggested, providing fuel for a full-scale RCT.

Eligibility Criteria

This trial is for patients with degenerative lumbar spondylolisthesis who've had back and leg pain for over 6 months that's better when sitting or bending forward. They should have tried other treatments without success and must speak English well enough to give informed consent and fill out questionnaires.

Inclusion Criteria

I have long-term back pain that gets better with rest and have not improved with basic treatments.
Sufficiently fluent in English to provide informed consent and complete questionnaires with or without the need of an interpreter.

Exclusion Criteria

I have had a fracture due to weak bones or I use steroid pills regularly.
I have had back surgery, but not a microdiscectomy.
I have a condition like MS, Parkinson's, or arthritis affecting my movement.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo either a midline or paramedian surgical approach for lumbar fusion

Surgery and immediate recovery
1 visit (in-person for surgery)

Initial Follow-up

Initial follow-ups to assess post-operative recovery and collect patient-reported outcomes

6 weeks
2 visits (in-person at 2 and 6 weeks)

Extended Follow-up

Further follow-up to monitor infection rates and other outcomes

3 months
1 visit (in-person at 3 months)

Long-term Follow-up

Participants are monitored for infection rates and other outcomes over a longer period

6 months

Treatment Details

Interventions

  • Surgical approach
Trial Overview The study compares two surgical approaches for treating lumbar spondylolisthesis: the midline approach versus the paramedian approach. It aims to see which one leads to lower infection rates, fewer repeat surgeries, shorter hospital stays, and less cost after surgery.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Paramedian ApproachExperimental Treatment1 Intervention
A paramedian (i.e. Wiltse) surgical approach will be used for the exposure required to complete the lumbar fusion.
Group II: Midline ApproachExperimental Treatment1 Intervention
A midline surgical approach will be used for the exposure required to complete the lumbar fusion.

Surgical approach is already approved in United States, European Union for the following indications:

๐Ÿ‡บ๐Ÿ‡ธ
Approved in United States as Spinal fusion for:
  • Degenerative lumbar spondylolisthesis
  • Isthmic spondylolisthesis
๐Ÿ‡ช๐Ÿ‡บ
Approved in European Union as Spinal fusion for:
  • Degenerative lumbar spondylolisthesis
  • Isthmic spondylolisthesis
๐Ÿ‡บ๐Ÿ‡ธ
Approved in United States as Decompressive laminectomy for:
  • Degenerative lumbar spondylolisthesis
  • Isthmic spondylolisthesis
๐Ÿ‡ช๐Ÿ‡บ
Approved in European Union as Decompressive laminectomy for:
  • Degenerative lumbar spondylolisthesis
  • Isthmic spondylolisthesis

Find a Clinic Near You

Who Is Running the Clinical Trial?

Nova Scotia Health Authority

Lead Sponsor

Trials
302
Recruited
95,300+

Andrew Glennie

Lead Sponsor

Trials
2
Recruited
100+

Findings from Research

Patients with degenerative spondylolisthesis who underwent decompression combined with fusion surgery experienced better outcomes compared to those who only received decompression surgery.
This suggests that adding fusion to decompression may enhance recovery and stability in patients with this condition.
Degenerative spondylolisthesis. To fuse or not to fuse.Feffer, HL., Wiesel, SW., Cuckler, JM., et al.[2022]
In a study of 50 adolescent and young adult patients with high-grade L5-S1 spondylolisthesis, a single posterior surgical approach effectively reduced slippage by over 50% and improved lumbosacral angle without loss of correction at follow-up, demonstrating its efficacy.
While the technique showed promising results, 34% of patients experienced transient postoperative radicular deficits, highlighting the need for careful patient counseling regarding potential risks.
Reduction and fusion in high-grade L5-S1 spondylolisthesis by a single posterior approach. Results in 50 patients.Moreau, S., Lonjon, G., Guigui, P., et al.[2018]
In a comparative cost-effectiveness study involving patients with stable Grade 1 degenerative lumbar spondylolisthesis, decompression surgery without instrumented fusion was found to be significantly more cost-effective, with a cost-utility ratio of $1,040 per quality-adjusted life-year (QALY) compared to $3,281 per QALY for decompression with fusion.
Decompression alone not only improved quality of life for selected patients but also offered potential cost savings, making it a preferable option for treating this condition in specific cases.
Cost-utility of lumbar decompression with or without fusion for patients with symptomatic degenerative lumbar spondylolisthesis.Kim, S., Mortaz Hedjri, S., Coyte, PC., et al.[2022]

References

Degenerative spondylolisthesis. To fuse or not to fuse. [2022]
Reduction and fusion in high-grade L5-S1 spondylolisthesis by a single posterior approach. Results in 50 patients. [2018]
Cost-utility of lumbar decompression with or without fusion for patients with symptomatic degenerative lumbar spondylolisthesis. [2022]
4.Czech Republicpubmed.ncbi.nlm.nih.gov
[Surgery for degenerative spondylolisthesis of the lumbar spine using intra-articular fusion. A prospective study]. [2014]
Biomechanical Evaluation of Lumbar Decompression Adjacent to Instrumented Segments. [2019]
Comparison of minimally invasive spine surgery using intraoperative computed tomography integrated navigation, fluoroscopy, and conventional open surgery for lumbar spondylolisthesis: a prospective registry-based cohort study. [2018]
Decompression Alone Compared to Decompression With Fusion in Patients With Lumbar Spondylolisthesis: Systematic Review, Meta-Analysis, and Meta-Regression. [2022]
Paraspinal Muscle Sparing Versus Percutaneous Screw Fixation: A Comparative Enzyme Study of Tissue Injury during the Treatment of L4-L5 Spondylolisthesis. [2020]
Hybrid technique for posterior lumbar interbody fusion: a combination of open decompression and percutaneous pedicle screw fixation. [2021]
10.Korea (South)pubmed.ncbi.nlm.nih.gov
Paraspinal Muscle Sparing versus Percutaneous Screw Fixation : A Prospective and Comparative Study for the Treatment of L5-S1 Spondylolisthesis. [2021]
11.United Statespubmed.ncbi.nlm.nih.gov
Three-Dimensional Navigated Lateral Lumbar Interbody Fusion: 2-Dimensional Operative Video. [2021]
12.United Statespubmed.ncbi.nlm.nih.gov
Decompression alone versus decompression and instrumented fusion for the treatment of isthmic spondylolisthesis: a randomized controlled trial. [2023]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity